Imaging Testing Diagnostic Type to Dominate Asia-Pacific Cancer Diagnostics Market During Forecast Period
Increasing prevalence of diseases is expected to
drive the growth of Asia-Pacific cancer diagnostics market during the forecast period.
According to
TechSci Research report, “Asia-Pacific
Cancer Diagnostics Market By Diagnostic Type (Lab Testing, Genetic Testing,
Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and
Others), By Technology (Platform Based, Instrument Based, Tumour Biomarker Tests),
By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer,
Kidney Cancer, Skin cancer, Others), By End-User (Diagnostic Centers, Hospitals
and Clinics, Research Institutes and Others), By Region, Forecast &
Opportunities, 2026”, the Asia-Pacific cancer
diagnostics market is expected to grow at a formidable CAGR during the forecast
period on account of increasing trend of
unhealthy diet amongst population in the region. This in turn leads to
increased count of patients suffering from diabetes and cancer, which is expected to propel the market over the next five
years. Furthermore, growing efforts undertaken by government to create
awareness regarding cancer, as well as to minimize the disease burden is
anticipated to positively impact the growth of market through 2026. Surging demand
for screening tools and techniques is further spurring the growth of market.
However, high cost of diagnosis might hamper the growth of market during
forecast period. Furthermore, several side effects
associated with imaging solutions is expected to
impede the growth of market over the next few years.
Browse XX market data Tables and XX Figures
spread through XXX Pages and an in-depth TOC on "Asia-Pacific
Cancer Diagnostics Market"
https://www.techsciresearch.com/report/asia-pacific-cancer-diagnostics-market/7303.html
The Asia-Pacific
cancer diagnostics market is segmented based on diagnostic type, technology,
application, end-user, company and region. Based on diagnostic type, the market
is categorized into lab testing, genetic testing, imaging testing, biomarkers
testing, in vitro diagnostic testing, biopsy and others. The imaging testing segment
dominated the market until 2020 and is expected to dominate the market during
forecast period as well. This dominance can be ascribed to the fact that imaging
modalities such as computed tomography scan and magnetic resonance imaging are
quick, non-invasive, and pain-free diagnostic solutions. In addition to this,
technological advancements in imaging modalities have contributed to the
segment growth. Based on end-user, the market can be fragmented into diagnostic
centers, hospitals and clinics, research institutes and others. The hospitals
and clinics segment is expected to dominate the market during the forecast
period on account of increased rates of adoption of technologically advanced
imaging modalities and other devices which are used in the detection of cancer.
Thermo Fisher
Scientific, Inc., GE Healthcare (A Subsidiary of General Electric Company),
Abbott Laboratories, Inc., Becton, Dickinson and Company, Siemens AG, Agilent
Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio Rad Laboratories Inc.,
Illumina, Inc., Boehringer-Ingelheim International GmbH and others are
some of the leading players operating in Asia-Pacific cancer diagnostics Market. The
companies operating in the market are using Go-to-Market strategies such as
product launches, mergers and acquisitions and research collaborations to boost
their share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7303
Customers can also request for 10% free
customization on this report.
“Asia-Pacific cancer
diagnostics market is expected to witness high growth in the market during the
forecast years owing to increasing healthcare expenditure and presence of a
large patient pool in the region. Additionally, thriving medical tourism
industry in developing economies such as India, China, and Malaysia is further
anticipated to spur the market growth. Also, presence of large market players along
with favorable government policies supporting the growth of the manufacturing
industry in the region is creating lucrative opportunities for the growth of cancer
diagnostics market in the upcoming years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Asia-Pacific Cancer Diagnostics Market By Diagnostic
Type (Lab Testing, Genetic Testing, Imaging Testing, Biomarkers Testing, In
Vitro Diagnostic Testing, Biopsy and Others), By Technology (Platform based,
Instrument based, Tumour Biomarker Tests), By Application (Lung Cancer, Breast Cancer,
Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin Cancer, Others), By
End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and
Others), By Region, Forecast & Opportunities, 2026”, has evaluated the future growth potential of Asia-Pacific
cancer diagnostics market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges and opportunities in Asia Pacific cancer
diagnostics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/